CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ACINETWORK focuses on developing glycoconjugate vaccines to combat antibiotic-resistant Acinetobacter baumannii infections. The project aims to create safer, more effective vaccines using defined synthetic antigens and to train new experts in vaccine development.
Bacterial infections are a societal burden with profound medical and socio-economic impacts.
Although antibiotics can be effective, the continuous emergence of bacteria with antimicrobial resistance calls for the introduction of novel therapeutics.
In this regard, glycoconjugate vaccines (GV) hold a prominent role in the fight against AMR bacterial strains.
They are based on the chemical conjugation of one or more pathogen-associated saccharide antigens to immunogenic carriers, leading to a long…
UNIVERSITA DEGLI STUDI DI MILANO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Florence
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, POTSDAM
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Spain, San Sebastian
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
